schizophrenia, depression,eating disorder, irritable bowel syndrome, Inflammatory bowel disease, gluten intolerance
Conditions
Interventions
gluten sensitive patients have gluten free diet for two weeks. Patients whose symptoms are improved continue gluten free diet for eight weeks.
Sponsors
Hyogo medical university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patient who met the criteria of depression, schizophrenia, irritable bowel syndrome and inflammatory bowel syndrome. patient who can understand the purpose of this study and be approved to participate by doctor . patient who can provide written informed consent.
Exclusion criteria
Exclusion criteria: patient with remarkable excitement, violent action, self-injurious behavior patient with social behavior patinet who can't provide written informed consent patient who have substance abuse or dependent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of gluten sensitivity is determined by the titer of tissue transglutaminase IgA antibody, the deamidated gliadin peptide IgA antibody, gliadin IgA antibody, gliadin IgGa nti body. | — |
Countries
Japan
Contacts
Public ContactYamada Hisashi
hyogo college of medicine department of neuropsychiatry
Outcome results
None listed